Stock Earnings

Question 1

What are Brainstorm Cell Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Brainstorm Cell Therapeutics Inc has a total asset of $1, Net loss of $-11

Question 2

What are the key financial ratios for BCLI?

Accepted Answer

Brainstorm Cell Therapeutics Inc's Current ratio is 0.11, has a Net margin is 0, sales per share of $0.

Question 3

How is Brainstorm Cell Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Brainstorm Cell Therapeutics Inc data is not available.

Question 4

Is Brainstorm Cell Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Brainstorm Cell Therapeutics Inc has a net loss of $-11

Question 5

Does Brainstorm Cell Therapeutics Inc have any liabilities?

Accepted Answer

yes, Brainstorm Cell Therapeutics Inc has liability of 9

Question 6

How many outstanding shares for Brainstorm Cell Therapeutics Inc?

Accepted Answer

Brainstorm Cell Therapeutics Inc has a total outstanding shares of 6.14

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	7	7	10	10	9	9
Research & Development	4	4	10	13	15	22
Operating Expenses	12	11	21	24	24	31
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-11	-11	-17	-24	-24	-31
Income Tax Expense	--	--	--	--	--	--
Net Income	-11	-11	-17	-24	-24	-31
Net Income Growth	-27%	-35%	-28.99%	0%	-23%	35%
Shares Outstanding (Diluted)	6.34	5.02	2.87	36.51	36.18	29.85
Shares Change (YoY)	47%	75%	-92%	1%	21%	36%
EPS (Diluted)	-1.74	-2.31	-5.98	-0.66	-0.68	-1.07
EPS Growth	-52%	-61%	807%	-3%	-36%	1%
Free Cash Flow	-7	-9	-20	-19	-26	-35
Free Cash Flow Per Share	-1.1	-1.79	-6.96	-0.52	-0.71	-1.17
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-12	-11	-21	-24	-24	-31
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-12	-11	-21	-24	-24	-31
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Brainstorm Cell Therapeutics Inc (BCLI) Price